CFG
66
6
NTRS
55
3
WAT
57
2
CSCO
51
3
MET
66
5
TDC
41
3
PH
69
3
ADSK
56
4
LRCX
58
9
MAC
47
3
SWK
28
4
EXPE
75
3
ACN
29
2
LOW
53
4
MCHP
54
7
NRG
75
3
SIG
35
4
STT
65
3
CNX
42
-7
KMB
28
-12
CFG
66
6
NTRS
55
3
WAT
57
2
CSCO
51
3
MET
66
5
TDC
41
3
PH
69
3
ADSK
56
4
LRCX
58
9
MAC
47
3
SWK
28
4
EXPE
75
3
ACN
29
2
LOW
53
4
MCHP
54
7
NRG
75
3
SIG
35
4
STT
65
3
CNX
42
-7
KMB
28
-12
Financhill
Back

Franklin Street Properties Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
17

FSP
Franklin Street Properties

Last Price:
$1.55
Seasonality Move:
-5.19%
Buy
66

SRPT
Sarepta Therapeutics

Last Price:
$60.45
Seasonality Move:
13.61%
Sell
17
Franklin Street Properties (FSP) is a Sell

Is Franklin Street Properties a Buy, Sell or Hold?

  • The current Franklin Street Properties [FSP] share price is $1.58. The Score for FSP is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • FSP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
66
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $61.76. The Score for SRPT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FSP Stock Price Chart

What is Franklin Street Properties's stock price today?

  • The Franklin Street Properties share price today is $1.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FSP is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $61.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

FSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 42.45 Sell
Chaikin Money Flow: -148838 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.52 - 1.82) Sell
Bollinger Bands (100): (1.68 - 1.94) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.72 Sell
Relative Strength Index (14 RSI): 44.97 Sell
Chaikin Money Flow: 1413454 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.5 - 69.5) Buy
Bollinger Bands (100): (75.99 - 127.65) Sell

FSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.53 Buy
20-day SMA: 1.62 Sell
50-day SMA: 1.77 Sell
200-day SMA: 1.76 Sell
8-day EMA: 1.55 Buy
20-day EMA: 1.61 Sell
50-day EMA: 1.71 Sell
200-day EMA: 1.81 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.57 Buy
20-day SMA: 57.74 Buy
50-day SMA: 81.94 Sell
200-day SMA: 116.58 Sell
8-day EMA: 57.69 Buy
20-day EMA: 61.26 Buy
50-day EMA: 77.18 Sell
200-day EMA: 106.29 Sell

Franklin Street Properties Earnings Growth & FSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.

Franklin Street Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):